Dobutamine: Difference between revisions

 
(20 intermediate revisions by 9 users not shown)
Line 1: Line 1:
==General==
==General==
*Type: [[Vasopressors]]
*Type: [[Vasopressors]]
**Technically an inotrope as beta 2 stimulation causes vasodilation
**Should use in combination with a [[Vasopressors|vasopressor]] (eg [[norepinephrine]]) to avoid hypotension
*Dosage Forms:
*Dosage Forms:
*Common Trade Names:
*Common Trade Names:


==Adult Dosing==
==Adult Dosing==
===Dosing===
*2-20mcg/kg/min
**10mcg works for most
*May use in peripheral IV
===Rate of Titration===
*Q2-5 min


==Pediatric Dosing==
==Pediatric Dosing==


==Special Populations==
==Special Populations==
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]:
*[[Drug Ratings in Pregnancy|Pregnancy Rating]]: B
*Lactation:
*Lactation:
** Unknown if Dobutamine passes into breast milk
*Renal Dosing
*Renal Dosing
**Adult
**Adult
*** Not defined
**Pediatric
**Pediatric
*** Not defined
*Hepatic Dosing
*Hepatic Dosing
**Adult
**Adult
*** Not defined
**Pediatric
**Pediatric
*** Not defined


==Contraindications==
==Contraindications==
Line 22: Line 35:


==Adverse Reactions==
==Adverse Reactions==
*Tachyarrhythmias
*Myocardial ischemia
*[[Hypotension]] as β<sub>2</sub> effect may result in vasodilation
**Caution if SBP <90
===Serious===
===Serious===


===Common===
===Common===


==Pharmacology==
==Pharmacology<ref>Dobutamine: Drug information. UpToDate. www.uptodate.com. Accessed April 2, 2019. </ref>==
*Half-life:  
*Half-life:  
** 2 minutes
*Metabolism:  
*Metabolism:  
** In tissues and hepatically
*Excretion:  
*Excretion:  
*Mechanism of Action:
** Urine as metabolites
*Mechanism of Action:β<sub>1</sub> stimulation with variable BP effects
===Primary Receptor===
*β<sub>1</sub>
*β<sub>2</sub>
===Relative Effects===
*↑↑↑SV
*↑↑HR → increases oxygen demand of heart → can worsen ischemia
*↓SVR (transient, from β<sub>2</sub> agonism)
 
==Notes==
===Indications===
*Cardiogenic shock
**initial agent in low-output heart failure without requiring BP support
*Tricyclic overdose
*septic shock with low cardiac output to improve blood flow


==See Also==
==See Also==
http://www.atsjournals.org/doi/abs/10.1164/rccm.201006-0972CI?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed#readcube-epdf


==Sources==
==References==
<references/>


<references/>
[[Category:Pharmacology]] [[Category:Critical Care]]
[[Category:Drugs]]

Latest revision as of 10:33, 4 January 2022

General

  • Type: Vasopressors
    • Technically an inotrope as beta 2 stimulation causes vasodilation
    • Should use in combination with a vasopressor (eg norepinephrine) to avoid hypotension
  • Dosage Forms:
  • Common Trade Names:

Adult Dosing

Dosing

  • 2-20mcg/kg/min
    • 10mcg works for most
  • May use in peripheral IV

Rate of Titration

  • Q2-5 min

Pediatric Dosing

Special Populations

  • Pregnancy Rating: B
  • Lactation:
    • Unknown if Dobutamine passes into breast milk
  • Renal Dosing
    • Adult
      • Not defined
    • Pediatric
      • Not defined
  • Hepatic Dosing
    • Adult
      • Not defined
    • Pediatric
      • Not defined

Contraindications

  • Allergy to class/drug

Adverse Reactions

  • Tachyarrhythmias
  • Myocardial ischemia
  • Hypotension as β2 effect may result in vasodilation
    • Caution if SBP <90

Serious

Common

Pharmacology[1]

  • Half-life:
    • 2 minutes
  • Metabolism:
    • In tissues and hepatically
  • Excretion:
    • Urine as metabolites
  • Mechanism of Action:β1 stimulation with variable BP effects

Primary Receptor

  • β1
  • β2

Relative Effects

  • ↑↑↑SV
  • ↑↑HR → increases oxygen demand of heart → can worsen ischemia
  • ↓SVR (transient, from β2 agonism)

Notes

Indications

  • Cardiogenic shock
    • initial agent in low-output heart failure without requiring BP support
  • Tricyclic overdose
  • septic shock with low cardiac output to improve blood flow

See Also

http://www.atsjournals.org/doi/abs/10.1164/rccm.201006-0972CI?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed#readcube-epdf

References

  1. Dobutamine: Drug information. UpToDate. www.uptodate.com. Accessed April 2, 2019.